Since our aim is to find a target and strategy to extend the time window and reduce tPA thrombolysis-associated hemorrhage transformation, we investigated the mechanism underlying BBB damage within the thrombolytic time window and we did not investigate the effect of the apocynin on infarction size either. The gene discussed is PLAT; the disease is infarction.